scholarly journals Dynamic Perfusion CT – A Promising Tool to Diagnose Pancreatic Ductal Adenocarcinoma

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S883-S884
Author(s):  
I. Zaborienė ◽  
K. Žvinienė ◽  
S. Lukoševičius ◽  
P. Ignatavičius ◽  
A. Gulbinas ◽  
...  
Open Medicine ◽  
2021 ◽  
Vol 16 (1) ◽  
pp. 284-292
Author(s):  
Inga Zaborienė ◽  
Giedrius Barauskas ◽  
Antanas Gulbinas ◽  
Povilas Ignatavičius ◽  
Saulius Lukoševičius ◽  
...  

Abstract Background and objective This study deals with an important issue of setting the role and value of the dynamic computed tomography (CT) perfusion analysis in diagnosing pancreatic ductal adenocarcinoma (PDAC). The study aimed to assess the efficacy of perfusion CT in identifying PDAC, even isodense or hardly depicted in conventional multidetector computed tomography. Methods A total of 56 patients with PDAC and 56 control group patients were evaluated in this study. A local perfusion assessment, involving the main perfusion parameters, was evaluated for all the patients. Sensitivity, specificity, positive, and negative predictive values for each perfusion CT parameter were defined using cutoff values calculated using receiver operating characteristic curve analysis. We accomplished logistic regression to identify the probability of PDAC. Results Blood flow (BF) and blood volume (BV) values were significant independent diagnostic criteria for the presence of PDAC. If both values exceed the determined cutoff point, the estimated probability for the presence of PDAC was 97.69%. Conclusions Basic CT perfusion parameters are valuable in providing the radiological diagnosis of PDAC. The estimated BF and BV parameters may serve as independent diagnostic criteria predicting the probability of PDAC.


Pharmaceutics ◽  
2022 ◽  
Vol 14 (1) ◽  
pp. 137
Author(s):  
Eun-Jeong Won ◽  
Hyeji Park ◽  
Tae-Jong Yoon ◽  
Young-Seok Cho

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide, and its incidence is increasing. PDAC often shows resistance to several therapeutic modalities and a higher recurrence rate after surgical treatment in the early localized stage. Combination chemotherapy in advanced pancreatic cancer has minimal impact on overall survival. RNA interference (RNAi) is a promising tool for regulating target genes to achieve sequence-specific gene silencing. Here, we summarize RNAi-based therapeutics using nanomedicine-based delivery systems that are currently being tested in clinical trials and are being developed for the treatment of PDAC. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) genome editing has been widely used for the development of cancer models as a genetic screening tool for the identification and validation of therapeutic targets, as well as for potential cancer therapeutics. This review discusses current advances in CRISPR/Cas9 technology and its application to PDAC research. Continued progress in understanding the PDAC tumor microenvironment and nanomedicine-based gene therapy will improve the clinical outcomes of patients with PDAC.


2019 ◽  
Vol 26 (11) ◽  
pp. 1829-1834
Author(s):  
Abdul Raouf ◽  
Adeela Abid Bukhari ◽  
Natasha Arshad ◽  
Muhammad Ahsan

Pancreatic ductal carcinoma is the most common primary malignancy of the pancreas and is associated with a very poor prognosis, being worldwide one of the leading cause of cancer related death. The pre-operative correct identification of this group of patients is very important to minimize unnecessary resections but remains difficult owing to the post-operative assessment of some factors such as tumor resection margins and grading. Perfusion CT (P-CT) is a new imaging technique able to provide qualitative and quantitative information on perfusion parameters of tissues, which have been demonstrated to be correlated with histological markers of angiogenesis. Objectives: To estimate the diagnostic accuracy of CT perfusion using PEI in detecting high grade pancreatic ductal adenocarcinoma keeping histopathology as gold standard. Study Design: Cross sectional study. Setting: Radiology department of Allied Hospital Faisalabad. Period: 6 months after approval from June, 2016 to Nov, 2016. Material and Methods: Permission for research was sought from hospital ethical committee. Patients were collected from OPD & indoor of Radiology and surgical department of Allied Hospital Faisalabad. Confounding variables were controlled by restriction (by excluding the subjects with history of metastatic disease or chemotherapy). CT-Perfusion examination was performed with the patient in supine position on a 128 slice Optima Multi detector CT scanner. Image guided (CT guided) biopsy was done on all patients and specimen was sent to the hospital pathology lab and histopathology was done by senior pathologist, who kept blinded to perfusion-CT analysis. Results: In this study, out of 100 cases, the diagnostic accuracy of CT perfusion using PEI in detecting high grade pancreatic ductal adenocarcinoma keeping histopathology as gold standard was recorded as 90.59%, 91.49%, 92.31%, 89.58% and 91% for sensitivity, specificity, positive predictive value, negative predictive value and accuracy rate. Conclusion: We concluded that diagnostic accuracy of CT perfusion using PEI is higher in detection of high grade pancreatic ductal adenocarcinoma keeping histopathology as gold standard. 


2000 ◽  
Vol 15 (11) ◽  
pp. 1333-1338 ◽  
Author(s):  
Koji Uno ◽  
Takeshi Azuma ◽  
Masatsugu Nakajima ◽  
Kenjiro Yasuda ◽  
Takanobu Hayakumo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document